June 2020 Clinical Watch Newsletter

July 8, 2020

In this issue of Clinical Watch, we discuss nitrosamine impurities found in widely used medications and suggest prior authorization criteria for a new treatment for heavy menstrual bleeding due to uterine fibroids. Lastly, we review claims data to identify the most frequently used contraceptive formulations.

For more information about a specific topic, please contact Janelle Sheen or Karen Powell. Be sure to stay tuned for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.

Previous Flipbook
July 2020 Clinical Watch Newsletter
July 2020 Clinical Watch Newsletter

In this issue of Clinical Watch, we discuss new antipsychotic medication formulations to tailor the managem...

Next Flipbook
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020
Healthcare Payer Operations – Services PEAK Matrix® Assessment 2020